Shetal Vyas

1 month ago | bioprocessonline.com | Ben Comer |Shetal Vyas |Denise N. Bronner |David W. Stowe

In the business of Uniquity Bio, Insmed, Chinese biotech and investment trends. Who — and what — is a life science leader in 2025? In the first month of my tenure as host of the Business of Biotech, it’s clearer to me than ever that leading in life sciences requires a constellation of expertise: strong leaders in drug development, in finance and operations, in policy and commercialization, and elsewhere. A broadening set of calculations is needed, to take and manage the risks required to succeed.